Your browser doesn't support javascript.
loading
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.
Takuva, Simbarashe; Karuna, Shelly T; Juraska, Michal; Rudnicki, Erika; Edupuganti, Srilatha; Anderson, Maija; De La Grecca, Robert; Gaudinski, Martin R; Sehurutshi, Alice; Orrell, Catherine; Naidoo, Logashvari; Valencia, Javier; Villela, Larissa M; Walsh, Stephen R; Andrew, Philip; Karg, Carissa; Randhawa, April; Hural, John; Gomez Lorenzo, Margarita M; Burns, David N; Ledgerwood, Julie; Mascola, John R; Cohen, Myron; Corey, Lawrence; Mngadi, Kathy; Mgodi, Nyaradzo M.
Afiliação
  • Takuva S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Karuna ST; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Juraska M; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Rudnicki E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Edupuganti S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Anderson M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • De La Grecca R; Division of Infectious Disease, Department of Medicine, Emory University, Atlanta, GA.
  • Gaudinski MR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Sehurutshi A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Orrell C; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Naidoo L; Botswana Harvard AIDS Institute, Gaborone, Botswana, South Africa.
  • Valencia J; Department of Medicine, Desmond Tutu HIV Center, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Villela LM; South African Medical Research Council, Durban, South Africa.
  • Walsh SR; Asociacion Civil Impacta Salud y Educacion, Lima, Peru.
  • Andrew P; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
  • Karg C; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.
  • Randhawa A; Family Health International, Durham, NC.
  • Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Gomez Lorenzo MM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Burns DN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Ledgerwood J; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Mascola JR; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Cohen M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Corey L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Mngadi K; Department of Medicine, University of North Carolina, Chapel Hill, NC.
  • Mgodi NM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
J Acquir Immune Defic Syndr ; 89(4): 405-413, 2022 04 01.
Article em En | MEDLINE | ID: mdl-34923559

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article